Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology
1
x
$
30.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
1
x
$
0.00
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
1
x
$
30.00
Escitalopram Induced SIADH in an Elderly Female: A Case Study
1
x
$
30.00
Fabiana da Silva Alves, MS: The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication
1
x
$
30.00
Can We Distinguish Anxiety From Depression?
1
x
$
30.00
VOL 2 No. 8 Full Issue - August 2000
1
x
$
20.00
Xin-Yun Lu, PhD, MD: Role of Central Melanocortin Signaling in Eating Disorders
1
x
$
30.00
The Sex Effects Scale: Pilot Validation in a Healthy Population
1
x
$
30.00
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
1
x
$
30.00
Jane P. Gagliardi, MD: Treatment of Thyrotoxicosis-Induced Psychosis
1
x
$
30.00
View Cart
Checkout
Home
matthew-brams
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
Page load link
Go to Top
